Atlas Trials

Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

Clinical trial NCT06589752 · COMPLETED

Trial details

NCT number
NCT06589752
Sponsor
Ruijin Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Primary IgA Nephropathy
Start date
2023-04-24
Primary completion
2024-09-05
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.